Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London u.a.
Acad. Press
1994
|
| Schriftenreihe: | Biologicals
22,4 |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010944096 | ||
| 003 | DE-604 | ||
| 005 | 19960912 | ||
| 007 | t| | ||
| 008 | 960911s1994 xx ad|| |||| 10||| engod | ||
| 035 | |a (OCoLC)164825668 | ||
| 035 | |a (DE-599)BVBBV010944096 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects |b 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 |c European Vaccines Manufacturers ... Ed. by F. André ... |
| 264 | 1 | |a London u.a. |b Acad. Press |c 1994 | |
| 300 | |a II S., S. 298 - 440 |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Biologicals |v 22,4 | |
| 500 | |a Einzelaufnahme eines Zs.-Heftes | ||
| 610 | 2 | 7 | |a Europäische Union |0 (DE-588)5098525-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kombinationspräparat |0 (DE-588)4197323-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1994 |z Brüssel |2 gnd-content | |
| 689 | 0 | 0 | |a Europäische Union |0 (DE-588)5098525-5 |D b |
| 689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | 2 | |a Kombinationspräparat |0 (DE-588)4197323-9 |D s |
| 689 | 0 | 3 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 1 | 1 | |a Kombinationspräparat |0 (DE-588)4197323-9 |D s |
| 689 | 1 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a André, F. E. |e Sonstige |4 oth | |
| 711 | 2 | |a European Conference on Vaccinology |n 2 |d 1994 |c Brüssel |j Sonstige |0 (DE-588)5182667-7 |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007319113 | |
Datensatz im Suchindex
| _version_ | 1820224377853050880 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010944096 |
| ctrlnum | (OCoLC)164825668 (DE-599)BVBBV010944096 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV010944096</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19960912</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960911s1994 xx ad|| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)164825668</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010944096</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects</subfield><subfield code="b">2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994</subfield><subfield code="c">European Vaccines Manufacturers ... Ed. by F. André ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London u.a.</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">II S., S. 298 - 440</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Biologicals</subfield><subfield code="v">22,4</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Heftes</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kombinationspräparat</subfield><subfield code="0">(DE-588)4197323-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1994</subfield><subfield code="z">Brüssel</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europäische Union</subfield><subfield code="0">(DE-588)5098525-5</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kombinationspräparat</subfield><subfield code="0">(DE-588)4197323-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Kombinationspräparat</subfield><subfield code="0">(DE-588)4197323-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">André, F. E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">European Conference on Vaccinology</subfield><subfield code="n">2</subfield><subfield code="d">1994</subfield><subfield code="c">Brüssel</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)5182667-7</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007319113</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1994 Brüssel gnd-content |
| genre_facet | Konferenzschrift 1994 Brüssel |
| id | DE-604.BV010944096 |
| illustrated | Illustrated |
| indexdate | 2025-01-03T10:47:18Z |
| institution | BVB |
| institution_GND | (DE-588)5182667-7 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007319113 |
| oclc_num | 164825668 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | II S., S. 298 - 440 Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Acad. Press |
| record_format | marc |
| series2 | Biologicals |
| spelling | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 European Vaccines Manufacturers ... Ed. by F. André ... London u.a. Acad. Press 1994 II S., S. 298 - 440 Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Biologicals 22,4 Einzelaufnahme eines Zs.-Heftes Europäische Union (DE-588)5098525-5 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Zulassung (DE-588)4127410-6 gnd rswk-swf Kombinationspräparat (DE-588)4197323-9 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1994 Brüssel gnd-content Europäische Union (DE-588)5098525-5 b Impfstoff (DE-588)4026655-2 s Kombinationspräparat (DE-588)4197323-9 s Zulassung (DE-588)4127410-6 s DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s André, F. E. Sonstige oth European Conference on Vaccinology 2 1994 Brüssel Sonstige (DE-588)5182667-7 oth |
| spellingShingle | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 Europäische Union (DE-588)5098525-5 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Zulassung (DE-588)4127410-6 gnd Kombinationspräparat (DE-588)4197323-9 gnd Impfstoff (DE-588)4026655-2 gnd |
| subject_GND | (DE-588)5098525-5 (DE-588)4143176-5 (DE-588)4127410-6 (DE-588)4197323-9 (DE-588)4026655-2 (DE-588)1071861417 |
| title | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 |
| title_auth | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 |
| title_exact_search | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 |
| title_full | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 European Vaccines Manufacturers ... Ed. by F. André ... |
| title_fullStr | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 European Vaccines Manufacturers ... Ed. by F. André ... |
| title_full_unstemmed | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 European Vaccines Manufacturers ... Ed. by F. André ... |
| title_short | Combined vaccines for Europe, pharmaceutical, regulatory and policy-making aspects |
| title_sort | combined vaccines for europe pharmaceutical regulatory and policy making aspects 2nd european conference on vaccinology proceedings brussels belgium 18 20 may 1994 |
| title_sub | 2nd European Conference on Vaccinology ; proceedings ; Brussels (Belgium), 18 - 20 May 1994 |
| topic | Europäische Union (DE-588)5098525-5 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Zulassung (DE-588)4127410-6 gnd Kombinationspräparat (DE-588)4197323-9 gnd Impfstoff (DE-588)4026655-2 gnd |
| topic_facet | Europäische Union Arzneimittelentwicklung Zulassung Kombinationspräparat Impfstoff Konferenzschrift 1994 Brüssel |
| work_keys_str_mv | AT andrefe combinedvaccinesforeuropepharmaceuticalregulatoryandpolicymakingaspects2ndeuropeanconferenceonvaccinologyproceedingsbrusselsbelgium1820may1994 AT europeanconferenceonvaccinologybrussel combinedvaccinesforeuropepharmaceuticalregulatoryandpolicymakingaspects2ndeuropeanconferenceonvaccinologyproceedingsbrusselsbelgium1820may1994 |